Detalhe da pesquisa
1.
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.
Blood
; 143(7): 592-596, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048557
2.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Hematol Oncol
; 42(4): e3290, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38818978
3.
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Lancet Oncol
; 24(1): 64-76, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528035
4.
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.
Hematol Oncol
; 40(5): 1009-1019, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35638723
5.
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.
Ann Hematol
; 99(2): 331-341, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31853703
6.
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.
Am J Hematol
; 91(10): 995-1001, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351715
7.
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.
Cytotherapy
; 17(10): 1485-93, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26188967
8.
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.
Blood Adv
; 8(6): 1529-1540, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231017
9.
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
Curr Oncol
; 30(11): 9710-9733, 2023 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999125
10.
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials.
Front Oncol
; 12: 890376, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924160
11.
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
Cancers (Basel)
; 13(11)2021 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34072068
12.
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis.
Cancers (Basel)
; 11(11)2019 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31694338
13.
The role of tandem stem cell transplantation for multiple myeloma patients.
Expert Opin Biol Ther
; 16(4): 515-34, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26698133
14.
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
Clin Lymphoma Myeloma Leuk
; 14(2): 148-54, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24417912
15.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.
J Clin Oncol
; 32(7): 634-40, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24449241
16.
A rare case of appendicular skeleton localization in a patient with chronic lymphocytic leukemia successfully treated with salvage radiation therapy.
Adv Radiat Oncol
; 3(2): 121-124, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29904735